Karin S. Blanchard

1.8k citations
8 papers · 1.4k indexed · 1 hit paper · h-index 7
Topics
Monoclonal and Polyclonal Antibodies Research (5 papers)Glycosylation and Glycoproteins Research (3 papers)RNA Interference and Gene Delivery (2 papers)
Partner nations
United States

In The Last Decade

Karin S. Blanchard

8 papers receiving 1.3k citations

Hit Papers

Potent and persistent in vivo anti-HBV activity of chemic...20052026201220192005250500750

Peers

Karin S. Blanchard
Comparison fields: 5 of 62
  • Molecular Biology 1.3k
  • Cancer Research 422
  • Genetics 192
  • Immunology 177
  • Epidemiology 147
Replace Shawn Zinnen with:
Shawn Zinnen United States
Kevin McClintock United States
Dianne Fang Canada
Fuh-Mei Duh United States
Ellen Ambegia Canada
Peer Papior Germany
Phong Trang United States
Xue F. Huang United States
Dong‐Soo Im South Korea
Y K Fung United States
Karin S. Blanchard relative to Shawn Zinnen United States Shawn Zinnen's profile →
Citations per field
00.5×1.5×
Shawn Zinnen · 1×
Citations per year

Countries citing papers authored by Karin S. Blanchard

Since Specialization
Citations

This map shows the geographic impact of Karin S. Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin S. Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin S. Blanchard more than expected).

Fields of papers citing papers by Karin S. Blanchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin S. Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin S. Blanchard. The network helps show where Karin S. Blanchard may publish in the future.

Co-authorship network of co-authors of Karin S. Blanchard

This figure shows the co-authorship network connecting the top 25 collaborators of Karin S. Blanchard. A scholar is included among the top collaborators of Karin S. Blanchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin S. Blanchard. Karin S. Blanchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsbreakdown →
908
2 219
3 6
4 38
5 29
6
Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.
129
7 31
8
Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYME) in healthy volunteers.
38

About Karin S. Blanchard

Karin S. Blanchard is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology and Molecular Biology, having authored 8 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (422 citations), Molecular Biology (1.3k citations) and Hepatology (85 citations). Karin S. Blanchard has collaborated with scholars based in United States. Frequent co-authors include Shawn Zinnen, Chandra Vargeese, Barry Polisky, Jennifer A. Lockridge, Kristi Jensen, Keith Bowman, Dylan Morrissey, Ian MacLachlan, Lloyd B. Jeffs and Susan F. Radka. Their work appears in journals such as Nature Biotechnology, Hepatology and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026